The weight-loss drugs Ozempic and Wegovy have captured headlines, but the medications remain out of reach for many. A shortage, the high cost and potential side effects have some turning to natural, ...
CAMPBELL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its ...